Local biotech teams are making progress on their Covid-19 vaccine candidates.
Pasadena-based biopharmaceutical startup Protomer Technologies Inc. has closed a second investment raise for a drug platform that includes an insulin product.
In one of the largest genomic medicine ventures in the nation, UCLA Health has entered into a research agreement with Regeneron Pharmaceuticals.
El Segundo telehealth provider Cloudbreak Health has agreed to be acquired by a special purpose acquisition company and will join UpHealth Holdings Inc.
Shares of online prescription drug price service GoodRx Holdings Inc. have fallen nearly 28% in two days.
The John Wayne Cancer Institute at Providence Saint John’s Health Center in Santa Monica has received its largest donation to date.
Primary care practices are struggling to stay afloat as Covid-19 cases are rising to record levels in Los Angeles County.
In its first quarterly earnings report last week as a public company, GoodRx Holdings Inc. posted solid revenue gains.
Temple City-based Fulgent Genetics Inc. continues to reap a bonanza from Covid-19 testing.
When the Covid-19 pandemic hit in March, Darren Saravis, who runs medical device manufacturing company Nectar Inc. in Long Beach, was stunned to hear about the shortage of ventilators and the exorbitant prices hospitals had to pay for them.
A year ago, Duarte-based City of Hope launched AccessHope, a spinoff company that provides employees of large, self-insured employers access to its cancer treatment specialists.
Sawtelle-based diagnostic imaging services provider RadNet Inc. made a pair of announcements in late October that expand the company’s reach.
Santa Monica-based Ontrak Inc. last month took the next step in its effort to use big data to improve patient outcomes in managing chronic diseases.
Medical procedure coding and insurance billing is among the most tedious and least glamorous work in all of health care, yet for Culver City-based GeBBS Healthcare Solutions Inc., these mundane tasks have been the ticket for explosive growth.
Patrick Soon-Shiong is stepping aside as chief executive of El Segundo-based biotech firm NantKwest Inc. and handing the reins to veteran health care executive Richard Adcock.